These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 12915339

  • 1. Long-term experience with levetiracetam.
    Abou-Khalil B, Lazenby B.
    Epileptic Disord; 2003 May; 5 Suppl 1():S33-7. PubMed ID: 12915339
    [Abstract] [Full Text] [Related]

  • 2. Preliminary efficacy of levetiracetam in monotherapy.
    Ben-Menachem E.
    Epileptic Disord; 2003 May; 5 Suppl 1():S51-5. PubMed ID: 12915342
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of levetiracetam in partial seizures.
    Devinsky O, Elger C.
    Epileptic Disord; 2003 May; 5 Suppl 1():S27-31. PubMed ID: 12915338
    [Abstract] [Full Text] [Related]

  • 6. Safety profile of levetiracetam.
    Arroyo S, Crawford P.
    Epileptic Disord; 2003 May; 5 Suppl 1():S57-63. PubMed ID: 12915343
    [Abstract] [Full Text] [Related]

  • 7. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP, Ricker L, Diepman L, Gehring J, Hulsman J, Lambrechts D, Leenen L, Majoie M, Schellekens A, de Krom M, Aldenkamp AP.
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG, Berkovic SF, Black AB, Danta G, Hiersemenzel R, Schapel GJ, Vajda FJ.
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [Abstract] [Full Text] [Related]

  • 9. Levetiracetam: a new therapeutic option for refractory epilepsy.
    Pinto A, Sander JW.
    Int J Clin Pract; 2003 Sep; 57(7):616-21. PubMed ID: 14529064
    [Abstract] [Full Text] [Related]

  • 10. The SKATE study: an open-label community-based study of levetiracetam as add-on therapy for adults with uncontrolled partial epilepsy.
    Steinhoff BJ, Somerville ER, Van Paesschen W, Ryvlin P, Schelstraete I.
    Epilepsy Res; 2007 Aug; 76(1):6-14. PubMed ID: 17681453
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age.
    Krief P, Li Kan, Maytal J.
    J Child Neurol; 2008 May; 23(5):582-4. PubMed ID: 18448575
    [Abstract] [Full Text] [Related]

  • 12. Role of levetiracetam in the treatment of epilepsy.
    Brodie MJ, French JA.
    Epileptic Disord; 2003 May; 5 Suppl 1():S65-72. PubMed ID: 12915344
    [Abstract] [Full Text] [Related]

  • 13. Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age.
    Perry S, Holt P, Benatar M.
    J Child Neurol; 2008 May; 23(5):515-9. PubMed ID: 18182645
    [Abstract] [Full Text] [Related]

  • 14. Levetiracetam monotherapy for late poststroke seizures in the elderly.
    Kutlu G, Gomceli YB, Unal Y, Inan LE.
    Epilepsy Behav; 2008 Oct; 13(3):542-4. PubMed ID: 18539085
    [Abstract] [Full Text] [Related]

  • 15. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM, Arts WF, ten Houten R, Augustijn P, Gunning WB, Peeters EA, Weber AM, Stroink H, Geerts Y, Geerts AT, Brouwer OF.
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [Abstract] [Full Text] [Related]

  • 16. Levetiracetam: a long-term follow-up study of efficacy and safety.
    Bauer J, Ben-Menachem E, Krämer G, Fryze W, Da Silva S, Kasteleijn-Nolst Trenité DG.
    Acta Neurol Scand; 2006 Sep; 114(3):169-76. PubMed ID: 16911344
    [Abstract] [Full Text] [Related]

  • 17. The SKATE study: interim analysis.
    Olwen GO.
    Int J Clin Pract; 2003 Sep; 57(6):544-5. PubMed ID: 12918896
    [Abstract] [Full Text] [Related]

  • 18. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
    Kaminski RM, Matagne A, Patsalos PN, Klitgaard H.
    Epilepsia; 2009 Mar; 50(3):387-97. PubMed ID: 18627416
    [Abstract] [Full Text] [Related]

  • 19. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE, Benbadis S, Edrich P, Tassinari CA, Hirsch E.
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [Abstract] [Full Text] [Related]

  • 20. Levetiracetam in absence epilepsy.
    Verrotti A, Cerminara C, Domizio S, Mohn A, Franzoni E, Coppola G, Zamponi N, Parisi P, Iannetti P, Curatolo P.
    Dev Med Child Neurol; 2008 Nov; 50(11):850-3. PubMed ID: 18808424
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.